Literature DB >> 16436637

Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma.

Adam Steg1, Wenquan Wang, Carmelo Blanquicett, Jessica M Grunda, Isam A Eltoum, Kangsheng Wang, Donald J Buchsbaum, Selwyn M Vickers, Suzanne Russo, Robert B Diasio, Andra R Frost, Al F LoBuglio, William E Grizzle, Martin R Johnson.   

Abstract

Recent studies have shown the hedgehog and Wnt families of signaling proteins to be associated with tumor initiation, growth, and survival. However, these pathways remain unexplored in ovarian endometrioid adenocarcinoma (OEA). Here, we describe a novel TaqMan low-density array to examine the expression of 26 and 20 genes in the hedgehog and Wnt pathways, respectively, in six matched snap-frozen and formalin-fixed, paraffin-embedded (FPE) OEA specimens. Expression values were normalized to uninvolved ovarian epithelium. Gene expression in matched frozen and FPE tissues demonstrated significant concordance (r = 0.92, P < 0.0001). However, comparison of amplified and unamplified RNA from frozen OEA tissues revealed an altered molecular profile in amplified RNA. Amplification of RNA from FPE tissues was not successful. The expression of Desert hedgehog (DHH), Indian hedgehog (IHH), Hedge-hog interacting protein (HHIP), Wnt10B, Wnt9B, and Wnt inhibitory factor (WIF1) were tumor-specific with no detectable expression in normal ovarian epithelium. In addition, several genes were significantly (P < 0.025) down-regulated in OEA, including cyclin E2, Porcupine, c-Myc, and Axin 2 (4.8-, 3.6-, 2.9-, and 1.9-fold, respectively). TaqMan low-density array provides an effective multivariate technique for examining gene expression in RNA isolated from either snap-frozen or archival FPE tissues and can identify tumor-specific genes, possibly leading to novel treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436637      PMCID: PMC1867577          DOI: 10.2353/jmoldx.2006.040402

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  34 in total

Review 1.  The hedgehog signalling pathway in tumorigenesis and development.

Authors:  C Wicking; I Smyth; A Bale
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

2.  Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies.

Authors:  Carmelo Blanquicett; Martin R Johnson; Marty Heslin; Robert B Diasio
Journal:  Anal Biochem       Date:  2002-04-15       Impact factor: 3.365

Review 3.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Authors:  R Wu; Y Zhai; E R Fearon; K R Cho
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

5.  Cancer statistics, 2000.

Authors:  R T Greenlee; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  2000 Jan-Feb       Impact factor: 508.702

6.  Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.

Authors:  Zuzana Dobbie; Patrick Y Muller; Karl Heinimann; Christiane Albrecht; Daniel D'Orazio; Igor Bendik; Hansjakob Müller; Peter Bauerfeind
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

7.  Medulloblastoma growth inhibition by hedgehog pathway blockade.

Authors:  David M Berman; Sunil S Karhadkar; Andrew R Hallahan; Joel I Pritchard; Charles G Eberhart; D Neil Watkins; James K Chen; Michael K Cooper; Jussi Taipale; James M Olson; Philip A Beachy
Journal:  Science       Date:  2002-08-30       Impact factor: 47.728

8.  Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs.

Authors:  Albert Ricken; Paul Lochhead; Maria Kontogiannea; Riaz Farookhi
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

9.  Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.

Authors:  Makoto Kubo; Masafumi Nakamura; Akira Tasaki; Naoki Yamanaka; Hiroshi Nakashima; Masatoshi Nomura; Syoji Kuroki; Mitsuo Katano
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

10.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine.

Authors:  J Taipale; J K Chen; M K Cooper; B Wang; R K Mann; L Milenkovic; M P Scott; P A Beachy
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

View more
  39 in total

1.  Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer.

Authors:  Robert Cornelison; Zachary C Dobbin; Ashwini A Katre; Dae Hoon Jeong; Yinfeng Zhang; Dongquan Chen; Yuliya Petrova; Danielle C Llaneza; Adam D Steg; Laura Parsons; David A Schneider; Charles N Landen
Journal:  Clin Cancer Res       Date:  2017-08-04       Impact factor: 12.531

2.  Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.

Authors:  Adam D Steg; Kerri S Bevis; Ashwini A Katre; Angela Ziebarth; Zachary C Dobbin; Ronald D Alvarez; Kui Zhang; Michael Conner; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

3.  Issues in collecting, processing and storing human tissues and associated information to support biomedical research.

Authors:  William E Grizzle; Walter C Bell; Katherine C Sexton
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks.

Authors:  S Schmitt; K Kynast; P Schirmacher; E Herpel
Journal:  Virchows Arch       Date:  2015-08-14       Impact factor: 4.064

5.  Association of common KIBRA variants with episodic memory and AD risk.

Authors:  Jeremy D Burgess; Otto Pedraza; Neill R Graff-Radford; Meron Hirpa; Fanggeng Zou; Richard Miles; Thuy Nguyen; Ma Li; John A Lucas; Robert J Ivnik; Julia Crook; V Shane Pankratz; Dennis W Dickson; Ronald C Petersen; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  Neurobiol Aging       Date:  2010-12-24       Impact factor: 4.673

6.  Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Blake Goodman; Hee-Dong Han; Alpa M Nick; Rebecca L Stone; Robert L Coleman; Ronald D Alvarez; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-07-13       Impact factor: 12.531

7.  Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Authors:  Maja Kodani; Genyan Yang; Laura M Conklin; Tatiana C Travis; Cynthia G Whitney; Larry J Anderson; Stephanie J Schrag; Thomas H Taylor; Bernard W Beall; Robert F Breiman; Daniel R Feikin; M Kariuki Njenga; Leonard W Mayer; M Steven Oberste; Maria Lucia C Tondella; Jonas M Winchell; Stephen L Lindstrom; Dean D Erdman; Barry S Fields
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 8.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

9.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

10.  Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer.

Authors:  Lise Aa Sørby; Solveig N Andersen; Ida R K Bukholm; Morten B Jacobsen
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.